Annuncio pubblicitario
Italia markets close in 6 hours 37 minutes

  • FTSE MIB

    33.868,78
    +122,12 (+0,36%)
     

  • Dow Jones

    37.903,29
    +87,37 (+0,23%)
     

  • Nasdaq

    15.605,48
    -52,34 (-0,33%)
     

  • Nikkei 225

    38.236,07
    -37,98 (-0,10%)
     

  • Petrolio

    79,58
    +0,58 (+0,73%)
     

  • Bitcoin EUR

    54.072,04
    +977,54 (+1,84%)
     

  • CMC Crypto 200

    1.268,55
    -2,20 (-0,17%)
     

  • Oro

    2.315,10
    +4,10 (+0,18%)
     

  • EUR/USD

    1,0711
    -0,0007 (-0,06%)
     

  • S&P 500

    5.018,39
    -17,30 (-0,34%)
     

  • HANG SENG

    18.207,13
    +444,10 (+2,50%)
     

  • Euro Stoxx 50

    4.898,46
    -22,76 (-0,46%)
     

  • EUR/GBP

    0,8551
    -0,0001 (-0,02%)
     

  • EUR/CHF

    0,9771
    -0,0049 (-0,50%)
     

  • EUR/CAD

    1,4687
    -0,0019 (-0,13%)
     

MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30

MiMedx Group, Inc
·1 minuto per la lettura
MiMedx Group, Inc
MiMedx Group, Inc

MARIETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2023 after the market close on Monday, October 30, 2023. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13741654

ANNUNCIO PUBBLICITARIO

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com